227 related articles for article (PubMed ID: 19734167)
1. Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes.
Carrillo-Sepúlveda MA; Ceravolo GS; Fortes ZB; Carvalho MH; Tostes RC; Laurindo FR; Webb RC; Barreto-Chaves ML
Cardiovasc Res; 2010 Feb; 85(3):560-70. PubMed ID: 19734167
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.
Carrillo-Sepúlveda MA; Ceravolo GS; Furstenau CR; Monteiro Pde S; Bruno-Fortes Z; Carvalho MH; Laurindo FR; Tostes RC; Webb RC; Barreto-Chaves ML
PLoS One; 2013; 8(4):e61982. PubMed ID: 23637941
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
Rodríguez A; Fortuño A; Gómez-Ambrosi J; Zalba G; Díez J; Frühbeck G
Endocrinology; 2007 Jan; 148(1):324-31. PubMed ID: 17038553
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
[TBL] [Abstract][Full Text] [Related]
6. The modulation of vascular ATP-sensitive K+ channel function via the phosphatidylinositol 3-kinase-Akt pathway activated by phenylephrine.
Haba M; Hatakeyama N; Kinoshita H; Teramae H; Azma T; Hatano Y; Matsuda N
J Pharmacol Exp Ther; 2010 Aug; 334(2):673-8. PubMed ID: 20519555
[TBL] [Abstract][Full Text] [Related]
7. Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.
Chang Y; Li JY; Jayakumar T; Hung SH; Lee WC; Manubolu M; Sheu JR; Hsu MJ
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186909
[TBL] [Abstract][Full Text] [Related]
8. Triiodothyronine Potentiates Vasorelaxation via PKG/VASP Signaling in Vascular Smooth Muscle Cells.
Samuel S; Zhang K; Tang YD; Gerdes AM; Carrillo-Sepulveda MA
Cell Physiol Biochem; 2017; 41(5):1894-1904. PubMed ID: 28376489
[TBL] [Abstract][Full Text] [Related]
9. Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: a comparative study.
López RM; Pérez T; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):313-22. PubMed ID: 20584208
[TBL] [Abstract][Full Text] [Related]
10. Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia.
Bellik L; Vinci MC; Filippi S; Ledda F; Parenti A
Br J Pharmacol; 2005 Oct; 146(4):568-75. PubMed ID: 16086034
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta.
Nishimatsu H; Suzuki E; Nagata D; Moriyama N; Satonaka H; Walsh K; Sata M; Kangawa K; Matsuo H; Goto A; Kitamura T; Hirata Y
Circ Res; 2001 Jul; 89(1):63-70. PubMed ID: 11440979
[TBL] [Abstract][Full Text] [Related]
12. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.
Ferro A; Coash M; Yamamoto T; Rob J; Ji Y; Queen L
Br J Pharmacol; 2004 Oct; 143(3):397-403. PubMed ID: 15351777
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
[TBL] [Abstract][Full Text] [Related]
15. GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.
Nagareddy PR; MacLeod KM; McNeill JH
Cardiovasc Res; 2010 Jul; 87(1):177-86. PubMed ID: 20110336
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of serum-stimulated responses in vascular smooth muscle cell proliferation by 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone, a newly synthesized 1,4-naphthoquinone derivative.
Kim TJ; Yun YP
Biol Pharm Bull; 2007 Jan; 30(1):121-7. PubMed ID: 17202671
[TBL] [Abstract][Full Text] [Related]
17. Camptothecin inhibits platelet-derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells through inhibition of PI3K/Akt signaling pathway.
Park ES; Kang SI; Yoo KD; Lee MY; Yoo HS; Hong JT; Shin HS; Kim B; Yun YP
Exp Cell Res; 2013 Apr; 319(7):982-91. PubMed ID: 23328306
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
19. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells.
Woodsome TP; Polzin A; Kitazawa K; Eto M; Kitazawa T
J Cell Sci; 2006 May; 119(Pt 9):1769-80. PubMed ID: 16608882
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
